
Congrats to Mike for his work @NatMentHealth about which psychosis patient subgroups may benefit most from treatment with muscarinic receptor agonist Cobenfy: nature.com/articles/s4422…
#schizophrenia #precisionpsychiatry
English
HalassaLab
44 posts

@HalassaLab
Michael Halassa Lab School of Medicine Tufts University







